- Telehealth Visits
- Insurance plan information
Michael Peluso, MD
- Telehealth Visits
- Insurance plan information
Michael Peluso, MD
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Infectious Disease, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Infectious Diseases, University of California San Francisco - GME
Residency
- Internal Medicine, Brigham & Women's Hospital
Internship
- Internal Medicine, Brigham & Women's Hospital
Degree
- MD, Yale University School of Medicine
My research
Clinical trials
Long-term Impact of Infection With Novel Coronavirus (COVID-19)Opens in a new window
Recruiting
The median age of study participants at enrollment.SCOPE Analytic Treatment Interruption ProtocolOpens in a new window
Recruiting
The proportion of participants developing acute retroviral syndromeCAR-T Cells for HIV InfectionOpens in a new window
Recruiting
The primary safety outcome will be the number of participants reporting a new Grade 3 or greater adverse events assessed by Common Terminology Criteria for Adv...
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.